PP01.02 Molecular recurrence risk profiles in patients with early-stage NSCLC: Current standard of care compared to a prognostic and predictive 14-gene expression assay
Recommended Citation
Hufham J, Aversano J, Doleshal M, Harrington D. PP01.02 Molecular Recurrence Risk Profiles in Patients with Early-Stage NSCLC: Current Standard of Care Compared to a Prognostic and Predictive 14-gene Expression Assay. Journal of Thoracic Oncology. 2023/03/01/ 2023;18(3, Supplement):e10. doi:https://libkey.io/libraries/1712/10.1016/j.jtho.2022.09.028
Document Type
Abstract